By Benjamin Horney ( January 6, 2017, 7:16 PM EST) -- Private equity giant The Carlyle Group LP may sell New York-based herbal supplement maker Nature's Bounty Co., Bloomberg reported on Friday. According to the report, Carlyle has held discussions with unnamed advisers concerning a potential sale of Nature's Bounty, which could go for up to $6 billion on the open market. Carlyle hopes to find a buyer for the entire business, but would be willing to consider a separate sale of Nature's Bounty's international operations, the report said....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.